Dr. Jürg Zimmermann CML Chronic Myeloid Leukemia
"Dr. Jürg Zimmermann, a medicinal chemist, is the chemical inventor of the compound STI571 also called Gleevec''
Extract of Novartis
VIDEOS
Jürg Zimmermann & team - new treatment for Chronic Myelogenous Leukaemia
May 5, 2009, European Patent Office
Jürg Zimmermann - Drug against chronic myelogenous leukaemia - Interview
May 5, 2009, European Patent Office
Jürg Zimmermann - Drug against chronic myelogenous leukaemia - European Inventor Award
April 29, 2009, European Patent Office
Jürg Zimmermann & team - new treatment for Chronic Myelogenous Leukaemia
May 5, 2009, European Patent Office
Jürg Zimmermann - Drug against chronic myelogenous leukaemia - Interview
May 5, 2009, European Patent Office
Jürg Zimmermann - Drug against chronic myelogenous leukaemia - European Inventor Award
April 29, 2009, European Patent Office
See also History of CML